Predictors of QOL in Patients with Alopecia Areata
Journal of Investigative Dermatology, ISSN: 0022-202X, Vol: 142, Issue: 10, Page: 2646-2650.e3
2022
- 24Citations
- 20Captures
- 2Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations24
- Citation Indexes23
- 23
- CrossRef2
- Policy Citations1
- 1
- Captures20
- Readers20
- 20
- Mentions2
- News Mentions2
- 2
Most Recent News
Patient-Reported Burden of Severe Alopecia Areata: First Results from the Multinational Alopecia Areata Unmet Need Survey
Introduction Alopecia areata (AA) is an inflammatory autoimmune disease characterized by nonscarring hair loss that can range in severity from small patches to complete hair
Article Description
Although alopecia areata (AA) severity is often defined by the degree of scalp hair loss, its impact on QOL can also be a defining measure of severity. In this cross-sectional study (AA Disease Specific Program), 259 patients were surveyed for demographics, AA illness characteristics, QOL (Skindex-16 AA), and daily impairment (Work Productivity and Activity Impairment). The association between patient demographics and illness variables, the Skindex-16 AA scores, and the Work Productivity and Activity Impairment scores were analyzed using regression analyses. The mean age of patients was 39 years (51% female). Self-reported severity of current AA was rated as mild (21%), moderate (54%), and severe (25%). The highest impairment was observed for the Skindex-16 AA emotions and the Work Productivity and Activity Impairment daily activity performance scores. Although the degree of scalp hair loss (physician Severity of Alopecia Tool score) was not predictive of QOL, patients’ self-report of moderate or severe disease, sex (females more impacted), and eyebrow and eyelash involvement were predictors of diminished QOL, consistently and incrementally. The present results suggest patients’ perception of severity as well as the presence of eyelash and eyebrow hair loss are also impactful and should be considered in defining the severity of disease.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0022202X22002081; http://dx.doi.org/10.1016/j.jid.2022.02.019; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85133403455&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/35331716; https://linkinghub.elsevier.com/retrieve/pii/S0022202X22002081; https://dx.doi.org/10.1016/j.jid.2022.02.019
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know